Jennifer Buell - 15 Jun 2021 Form 4 Insider Report for AGENUS INC (AGEN)

Role: COO and President
Signature: /s/ Adam Krauss, as Attorney-in-Fact for Jennifer Buell
Issuer symbol: AGEN
Transactions as of: 15 Jun 2021
Transactions value $: $58,178
Form type: 4
Filing time: 02 Jul 2021, 19:34:01 UTC
Next filing: 20 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGEN	Common Stock	Award	$58,177	+10,597	+9.1%	$5.49	127,091	30 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGEN	Stock Option	Award	$0	+900,000		$0	900,000	15 Jun 2021	Common Stock	900,000	$3.18	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock issued is fully-vested on the date of issuance, but is subject to a 12-month lockup restriction.
F2	Option was granted on January 1, 2021, subject to shareholder approval of an increase to the available pool under the Company's 2019 Equity Incentive Plan ("2019 Plan"), which was obtained at the Company's annual shareholder meeting on June 15, 2021. Option awarded in accordance with the 2019 Plan. Option vests over a four-year period, with 1/3 of Option vesting on December 17, 2022, and the balance vesting in eight equal quarterly installments thereafter.

Content

The stock issued is fully-vested on the date of issuance, but is subject to a 12-month lockup restriction.

Option was granted on January 1, 2021, subject to shareholder approval of an increase to the available pool under the Company's 2019 Equity Incentive Plan ("2019 Plan"), which was obtained at the Company's annual shareholder meeting on June 15, 2021. Option awarded in accordance with the 2019 Plan. Option vests over a four-year period, with 1/3 of Option vesting on December 17, 2022, and the balance vesting in eight equal quarterly installments thereafter.